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Abstract
We offer a UK-based commentary on the recent “Perspective” published in IJHPM by Thakkar and Sullivan. 
We are sympathetic to the authors’ call for increased funding for health service and policy research (HSPR). 
However, we point out that increasing that investment – in any of the three countries they compare: Canada, 
the United States and the United Kingdom– will ipso facto not necessarily lead to any better use of research by 
health system decision-makers in these settings. We cite previous authors’ descriptions of the many factors that 
tend to make the worlds of researchers and decision-makers into “two solitudes.” And we call for changes in 
the structure and funding of HSPR, particularly the incentives now in place for purely academic publishing, to 
tackle a widespread reality: most published research in HSPR, as in other applied fields of science, is never read 
or used by the vast majority of decision-makers, working out in the “real world.”
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The importance of, and need for, robust health service and policy research (HSPR) is well articulated by Thakkar and Sullivan in their perspective article.1 They 
claim that the funding devoted to HSPR is not in keeping 
with its value and importance although, certainly as far as 
the United Kingdom is concerned, there are early signs that 
this imbalance has not only been acknowledged but is being 
actively addressed, as we will demonstrate. 
Strictly speaking, their comparison of “dollars spent” in 
2010 on HSPR in Canada, the United States and the United 
Kingdom, is incorrect, in that it fails to adjust for the fact that 
virtually all Canadian research grants – unlike those in the 
United States and the United Kingdom – pay no portion of 
any investigator’s salary, and only a paltry overhead to their 
institution (less than 20% of direct costs, in comparison 
with much larger “overheads” paid in the United States and 
the United Kingdom – eg, 50% of the grant value in the 
United States’s NIH grants, including all investigators’ salary 
support). Based on the second author’s many years of grant 
writing and adjudication in all three countries, he reckons 
that these differences mean that a grant for research costing 
“x” dollars in Canada typically costs about twice that (ie, “2x” 
dollars) in the United States, and slightly more in the United 
Kingdom. Thus Thakkar and Sullivan’s estimate, that US$3.76 
per capita was spent in Canada on HSPR in 2010, compared 
to US$6.46 per capita in the United States, would mean that 
about the same amount per capita was actually spent in the two 
countries on direct research costs, not including overhead and 
investigator salary support. [This has recently been pointed 
out by the Naylor Report on research policy and practice in 
Canada2 as a fundamental weakness of that system, in that 
research institutions effectively have to subsidize the full cost 
of doing research, putting them in a non-competitive position 
with research institutions in the United States and the United 
Kingdom.] However, we prefer to focus here on Thakkar and 
Sullivan’s main point: that HSPR funding could and should be 
more generous, in all three jurisdictions.
The authors refer to Berwick’s triple aim of improved 
population health, patient-centred care, and improved 
per capita care costs.3 This approach is at the centre of 
the significant transformation underway in the English 
National Health Service (NHS). Alongside the changes 
being implemented in regard to new models of care, there is 
significant investment in research to evaluate the impact of 
such changes and the accompanying barriers and facilitators, 
much of it funded by NHS England. The findings from these 
studies will be available shortly alongside a four-year national 
evaluation just commencing, funded by the National Institute 
for Health Research (the R&D wing of the English NHS). 
There seems to be no let-up in the appetite for more HSPR as 
far as the United Kingdom is concerned. 
However, we suggest that funding is not the only, or even 
the most pressing, problem confronting HSPR. It is worth 
reminding ourselves that there already exists a modest 
evidence base in regard to health policy implementation 
and what needs to happen for successful transformation in 
health systems to occur. Yet, in the constant pursuit of new 
research, and at the risk of further stockpiling it, there are 
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doubts concerning whether the extant body of research is 
being utilised to full effect. While we are not advocating a 
moratorium on new HSPR, unless it can be demonstrated 
that it is of value, especially at a time of fiscal constraint in 
public spending, then researchers could be leaving themselves 
vulnerable to challenge. Policy-makers among others are likely 
to call upon the research community to justify the existing 
investment in HSPR with potential implications for any 
significant increases in research regardless of how important 
and desirable it may be. 
It is also important to explore the reasons for why HSPR 
has not, until recently, been viewed as a mainstream area 
for investment. As health systems globally seek to transform 
themselves, there is a growing recognition that evidence of what 
works and why (or why not) is urgently needed. Virtually all 
health systems are confronting the same challenges in regard 
to how to implement change successfully and sustainably.4 If, 
as we suggest, the existing evidence base is not being used to 
best effect we need to understand the reasons for such a state 
of affairs before investing significant new funding. 
The reasons are multiple. Evidence often fails to impact 
on policy and practice because of failings among academic 
researchers whose findings take too long to produce, so 
that they miss the tide. Some of the reasons are beyond the 
power of the researcher to control and include delays arising 
from the bureaucratic and often painfully slow procedures 
displayed by ethics committees, research governance bodies 
and other hoops that have to be negotiated before any 
research can commence. Even when research studies are 
completed within a reasonable timeframe, the results are 
often perceived to be inaccessible and jargon-ridden and not 
presented in a format that engages busy managers and other 
health care professionals or gives them the information they 
need or are looking for. It is little wonder therefore that the 
output from think tanks and management consultants offers 
greater appeal because it is seen as timely and user-friendly — 
even if it lacks the academic rigour of sound, theory-driven, 
empirical research. 
The incentive structure for academics is largely biased 
towards seeking publication of research in high-impact, peer-
reviewed journals — rather than publishing in practitioner 
outlets which conceivably could have more impact on policy 
and practice. In the United Kingdom, the situation has begun 
to change with greater emphasis being placed upon impact. 
The last round of the Research Excellence Framework (the 
UK national competition for research financial support to 
universities, based on performance) in 2014 for the first time 
required the production of impact case studies to demonstrate 
the value in practice of funded research. While the shift to 
impact brings with it its own problems, in regard to spawning 
a new industry of case-study writers engaged in creative, and 
sometimes misleading, ways of demonstrating the value of 
research, the move has been generally welcomed. We therefore 
applaud the current effort to create epistemologically sound 
criteria for assessing whether a piece of research has had true 
societal impact while at the same time being mindful of a 
large existing literature which states that any one study should 
rarely be used as the basis for either policy or action, in that 
wherever possible replication is the essence of good science. 
Of course, we acknowledge in some complex contexts that 
may not be easy or always possible but it should be a goal to 
which researchers aspire.
In addition to the issue of impact, the way in which research 
proposals are designed, reviewed and implemented continues 
to place the emphasis upon, and privileges, academic-led 
research. This poses obstacles to providing useful, usable and 
timely research evidence in response to the needs of policy-
makers and practitioners.5 While terms like co-production, 
co-creation and knowledge brokerage have entered the 
research vocabulary, their meaning often remains vague 
and imprecise and such fashionable approaches can seem 
tokenistic. Academics by and large continue to set the agenda 
and the systems and procedures for applying for and meting 
out research funding generally reinforce this bias. 
But if HSPR is to have the impact it merits and is not 
going to disappoint end users, then those at whom the 
research is directed need to be involved at all stages of the 
research process from its inception through to dissemination 
of results.
HSPR is also difficult work and not always rewarding for 
academics accustomed to identifying clear cause and effect, 
and being able to definitively attribute change to particular 
interventions. By comparison with complex systems research, 
conducting systematic reviews of treatment effectiveness, 
and executing randomized controlled trials (RCTs) are 
straightforward and infinitely less problematic, in that the 
methods are well-codified globally. Conducting research in 
complex systems does not allow for such certainties or for tidy 
rational linear models to be adopted. Undertaking research in 
the messy real world where policies change with increasing 
rapidity, and “reform fatigue” and churn in the health system 
workforce are all too prevalent, add to the difficulties of 
conducting research to order. It is therefore hardly surprising 
that research in such contexts is not generalizable even if 
individual studies contribute to theory. Realist evaluation best 
captures the issues at stake here with its slogan, ‘what works 
for whom in what circumstances and why,’ being especially 
apposite.6 
Working in a complex and often unpredictable environment 
requires not just adequate funding but the appropriate mix 
of skills. These are not just technical research skills around 
methods and design but include soft skills needed for 
relationship-building and exercising political astuteness. The 
temporal challenge has to be managed in order to balance the 
desire for real time research on the one hand with the need 
to conduct rigorous and sound research that is seen to be 
credible on the other.
The authors claim a connection exists between the 
performance of a country’s health system and investment in 
HSPR but the evidence offered in support of this relationship 
is negligible. Certainly the claim made for improvements in 
health system performance and quality under the UK Labour 
governments between 1997 and 2010 owed little if anything to 
research. The driver for reform was a politically mandated top-
down management culture which adopted a ‘terror by targets’ 
regime. The Blair government was fixated on delivery and 
invested heavily in what has become known as ‘deliverology.’7 
None of this had anything of significance to do with research. 
Indeed, much HSPR research on health systems change was 
ignored in the pursuit of an ideology-based agenda around 
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privatisation, outsourcing and choice. Research critical of 
hospital mergers, for example, was ignored by a government 
which favoured them for largely political reasons. And 
research was consistently ignored that challenges the claims 
that opening up choice to patients improves care-system 
performance and quality of care.
An issue the paper does not deal with is the significant 
amount of in-house research that is conducted within health 
services but which is not included in the data on research 
funded through research councils and national programmes. 
Certainly in England, as noted earlier in regard to the current 
reforms underway, the NHS spends a significant amount 
on applied research undertaken by academics. Most of this 
research, which is sometimes categorised as consultancy, is 
not published and its impact on policy and practice remains 
unknown. 
If there is to be greater stakeholder investment in HSPR, 
then those charged with producing it need to pay more 
attention to issues around impact and value for money. 
Attention needs to be given to ensuring that research already 
stockpiled is made available and appropriately presented to 
health service managers and professionals. Only then – after 
thorough review of what is already known — should new 
research be commissioned that adopts, and is committed to, 
co-production principles. That means negotiating with those 
at whom the research is targeted to ensure that the questions 
they want answered are addressed. And finally, the research 
needs to be carried out in a timely manner with regular 
feedback in order to ensure that as evidence emerges it can 
inform policy changes as they are evolving, with the potential 
for correction and amendment as required. 
But it is not only researchers who need to up their game. 
Those who claim to want significant investment in HSPR and 
believe in its value need to be realistic in their expectations. 
Hard-pressed managers seeking quick wins in their efforts 
to transform services cannot expect favourable results to 
magically appear after a few months. For example, conducting 
health economics research on the cost-effectiveness of changes 
requires a significant longitudinal element in its design, to 
ensure sufficient confidence that there is a cost improvement 
over time. 
Finally, in securing successful HSPR, attention needs to 
be given to the skills and capabilities of those conducting 
research. If the preference is for research that is co-produced 
with key stakeholders, to ensure the right questions are asked 
and to increase the likelihood of the research findings being 
owned and implemented, then having researchers equipped 
with the requisite soft skills alongside their technical academic 
skills is essential. Such skills include being able to build 
relationships, demonstrate political astuteness, communicate 
effectively with different audiences. Emotional intelligence 
remains rather uncommon among researchers, and yet is vital 
for research that seeks to inform and influence policy and 
practice. We know from the experiences of centres involved 
in public health research capacity-building in the United 
Kingdom that being aware of such factors and developing 
researchers accordingly is important and achieves results.8 
Experiments with models such as the embedded researcher 
and researcher-in-residence that place researchers in policy 
and practice settings are demonstrating the value of bridging 
the academic research to policy and practice interface.9
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